Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04166045 · ClinicalTrials.gov registry record · NA
Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain
A NA study, sponsored by Theranova, L.L.C..
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04166045: Completed NA study, sponsored by Theranova, L.L.C..
NCT04166045 is a NA study that has completed, run by Theranova, L.L.C.. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04166045, a NA study, has completed, sponsored by Theranova, L.L.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Clinical study to determine the responder rate of the TheraNova Migraine Treatment System to that of a sham control treatment.
Primary Outcome
We will also assess the change in migraine pain before versus after treatment with the 100-mm Visual Analogue Scale (VAS), which is a continuum scale that patients can quantify their pain from none (0 mm) to extreme (100 mm) for both treatment sites. The mean score for each patient cohort will be calculated. We will also perform a sub analysis on women versus men.
Interventions
- DEVICE Sham Treatment Location
- DEVICE Verum Treatment Location
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2021-04-29 |
| Phase | NA |
What the finished NCT04166045 record still lists
NCT04166045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment Location is the first listed.
NCT04166045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04166045 about?
NCT04166045 is a clinical study titled "Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain". Clinical study to determine the responder rate of the TheraNova Migraine Treatment System to that of a sham control treatment.
What is the current status of trial NCT04166045?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-06-12. Estimated completion is 2021-04-29.
What interventions are being tested in trial NCT04166045?
The interventions under investigation include: Sham Treatment Location (DEVICE), Verum Treatment Location (DEVICE).
Who is sponsoring clinical trial NCT04166045?
This trial is sponsored by Theranova, L.L.C., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04166045's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI